“Before we can discover new treatments for brain-related diseases such as Alzheimer’s and Parkinson’s, we need to understand the human genetic blueprint – DNA – that determines how the brain works in healthy individuals,” he said. “Then we will be better equipped to develop new medicines and therapies for individuals with brain disorders.”Matt Huentelman, PhD, Professor, Neurogenomics Division, Translational Genomics Research Institute (TGen)
In this profile in the Phoenix Business Journal, Dr. Matt Huentelman explains how crowdsourcing and his goal of reaching 1 million people may hold the keys to understanding the genetic underpinnings of Alzheimer’s disease and other brain-related disorders.
Visit the Phoenix Business Journal
And meet the TGen Alzheimer’s expert who wants to test 1 million people.
YOU CAN MAKE A DIFFERENCE.
MindCrowd is the first online research project of its kind to study millions of individuals to help bring us closer to a cure for Dementia.
Help us reach the 1 million people mark.
Stay Tuned for News about Brain Aging and How you Can Use them to Avoid Cognitive Decline.